About The ESDR
The European Society for Dermatological Research (ESDR), founded in 1970, is a non-profit organization promoting basic and clinical science related to dermatology. The ESDR is the largest investigative dermatology society in Europe with a current membership of over 1200.
By supporting investigative dermatology, the ESDR contributes towards improving the health of patients suffering from skin and venereal disease. Applications of recent scientific advances have produced diagnostic and therapeutic innovations in dermatological practice, particularly in genetics, skin cancer, allergic skin disease, infectious disease and autoimmune diseases.
News
Explore the joy of scientific questioning and discovery in the inaugural issue of JID Innovations.
Read Russell P. Hall’s introductory editorial here. The entire issue can be found here:...
Registration for ESDR 2021 is open
Join the Virtual 50th Anniversary ESDR Annual Meeting.The ESDR Board and Program Committee are...
Promoting Science for Skin Regeneration
April 8-9, 2021: VIRTUAL MEETING, A new Society for...
ESDR 2021 MOVES TO VIRTUAL
Dear Colleague, As you will recall, we postponed our 50th Anniversary meeting to be held in...
ESDR mourns Prof Hiroshi Shimizu
We are very sad to learn of the passing of Prof Hiroshi Shimizu. Honorary member and great friend...
European Virtual Magic Wand educational program
The European Virtual Magic Wand Program will offer a unique opportunity for dermatologists in...
ABOUT JID
The Journal of Investigative Dermatology (JID) is the official journal of the ESDR and SID. JID publishes papers describing original research on all aspects of cutaneous biology and skin disease. Topics include biochemistry, biophysics, cell regulation, carcinogenesis, skin structure, extracellular matrix, genetics, immunology, melanocyte biology, microbiology, molecular and cell biology, pathology, physiology, pharmacology, photobiology, percutaneous absorption, clinical research, epidemiology and other population-based research.
JID Latest
- Inhibition of plasminogen activator inhibitor-1 blocks programmed death ligand 1 endocytosis and improves the response of melanoma cells to immune checkpoint blockade
- A targetable, non-canonical STAT3 activation induced by the tyrosine-less region of IL-22R orchestrates imiquimod-induced psoriasis-like dermatitis in mice
- Unsuspected Associations with Variants within the Genes NOTCH4 and STEAP2-ASI Uncovered by a Genome-Wide Association Study in Endemic Pemphigus Foliaceus
- The polyamine regulator AMD1 up-regulates spermine levels to drive epidermal differentiation
- LAMININ 332 IS INDISPENSABLE FOR HOMEOSTATIC EPIDERMAL DIFFERENTIATION PROGRAMS
